Early Data Show Promise for Galinpepimut-S and Opdivo in Mesothelioma Patients
A combination of the immunotherapy drugs galinpepimut-S and Opdivo may give mesothelioma patients a few extra months, according to newly-released…
A vast amount of studies suggest that immunotherapy may represent an effective new treatment approach for malignant mesothelioma. Learn your options here.